We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Importance of Different Modularity of the Polyethylene Insert for Tibial Component Migration and Adaptive Bone Remodeling After Uncemented Total Knee Arthroplasty Using Trabecular Metal Technology (TMT) Zimmer NexGen®, (Monoblock vs. Modular Design)

This study is ongoing, but not recruiting participants.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01637051
First Posted: July 10, 2012
Last Update Posted: October 29, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Zimmer Biomet
Information provided by (Responsible Party):
Mikkel Rathsach Andersen, Rigshospitalet, Denmark
  Purpose

In a prospective randomised study two uncemented tibial components with different polyethylene modularities (Trabecular Metal Technology (TMT) Zimmer NexGen® monobloc and TMT Zimmer NexGen® modular) used for total knee arthroplasty (TKA) is evaluated. Both tibial component coatings are designed to provide excellent condition for bone ingrowth.

The differences between the two tibial components are evaluated by measurements of migration of the tibial component assessed by Radiostereometric analysis (RSA) and measurements of the adaptive bone remodeling of the proximal tibial assessed by dual energy X-ray absorptiometry (DEXA).


Condition Intervention
Arthrosis of the Knee Device: Zimmer NexGen® Trabecular Metal Technology (TMT), Monoblock Device: Zimmer NexGen® Trabecular Metal Technology (TMT), Modular

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: The Importance of Different Modularity of the Polyethylene Insert for Tibial Component Migration and Adaptive Bone Remodeling After Uncemented Total Knee Arthroplasty Using Trabecular Metal Technology (TMT) Zimmer NexGen®, (Monoblock vs. Modular Design)

Resource links provided by NLM:


Further study details as provided by Mikkel Rathsach Andersen, Rigshospitalet, Denmark:

Primary Outcome Measures:
  • migration of tibial component [ Time Frame: three years ]
    The differences between two tibial components are evaluated by measurements of migration of the tibial component assesed by Radiostereometric analysis (RSA) and measurements of the adaptive bone remodeling of the proximal tibial assesed by dual energy X-ray absorpitiometry (DEXA).


Secondary Outcome Measures:
  • Knee function [ Time Frame: three years ]
    knee function postoperativly assessed by Oxford Knee Score


Estimated Enrollment: 60
Study Start Date: July 2012
Estimated Study Completion Date: August 2025
Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Zimmer NexGen®, Trabecular Metal Technology (TMT) Monoblock
The tibial component has a monoblock design
Device: Zimmer NexGen® Trabecular Metal Technology (TMT), Monoblock

A prospective randomized study where the patients are randomized too receive a monoblock tibial component with trabecular metal coating (TMT Zimmer NexGen®) or a modular tibial component (TMT Zimmer NexGen®). Both prostheses are available and approved by the FDA and CE. The only difference between the implants is that of the polyethylene insert (monoblock vs. modular).

The operations are performed at the Department of Planned Elective Surgery Z, Gentofte Hospital by two experienced TKA surgeons that will be included in the research group. During surgery a minimum of 4 Tantalum markers (0.8 mm) is inserted in the bone of the proximal tibia and 6 markers are inserted in the polyethylene insert.

Zimmer NexGen® Trabecular Metal Technology (TMT), Modular
The tibial component has a modular design
Device: Zimmer NexGen® Trabecular Metal Technology (TMT), Modular

A prospective randomized study where the patients are randomized too receive a monoblock tibial component with trabecular metal coating (TMT Zimmer NexGen®) or a modular tibial component (TMT Zimmer NexGen®). Both prostheses are available and approved by the FDA and CE. The only difference between the implants is that of the polyethylene insert (monoblock vs. modular).

The operations are performed at the Department of Planned Elective Surgery Z, Gentofte Hospital by two experienced TKA surgeons that will be included in the research group. During surgery a minimum of 4 Tantalum markers (0.8 mm) is inserted in the bone of the proximal tibia and 6 markers are inserted in the polyethylene insert.


  Show Detailed Description

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   40 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

The participants of the study are patients that have been scheduled for a primary TKA using the usual indications for TKA at the Department of Planned Elective Surgery Z, Gentofte Hospital.

Inclusion Criteria:

  • Severe osteoarthrosis of the knee with indication for a TKA.
  • Age between 40 and 70 years.

Exclusion Criteria:

  • Diseases affecting the bone metabolism (osteoporosis, Pagets disease, hyperparathyreoidism etc.).
  • Patients estimated not to be able to understand the "Information to patients" papers or do not want to participate in the study.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01637051


Locations
Denmark
Gentofte Hospital
Copenhagen, Denmak, Denmark, 2900
Gentofte Hospital
Copenhagen, Denmark, 2900
Sponsors and Collaborators
Rigshospitalet, Denmark
Zimmer Biomet
Investigators
Principal Investigator: Mikkel Rathsach Andersen, Ph.D Rigshospitalet, Denmark
  More Information

Publications:

Responsible Party: Mikkel Rathsach Andersen, Læge, Ph.D, Rigshospitalet, Denmark
ClinicalTrials.gov Identifier: NCT01637051     History of Changes
Other Study ID Numbers: H-1-2012-033
First Submitted: July 6, 2012
First Posted: July 10, 2012
Last Update Posted: October 29, 2015
Last Verified: October 2015

Additional relevant MeSH terms:
Joint Diseases
Musculoskeletal Diseases